BioVie (BIVI) Stock Chart & Stock Price History $1.65 -1.26 (-43.26%) Closing price 03:59 PM EasternExtended Trading$1.66 +0.00 (+0.24%) As of 04:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioVie Stock Price Performance The BioVie (BIVI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 93.32%, with a year-to-date return of -91.75%. In the past month, the stock has decreased 80.51%, reflecting recent market activity. As of the latest close, BioVie traded at $2.91 with a market cap of $5.41 million and volume of 406,276 shares. Receive BIVI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-72.62%1 Month Performance-80.51%3 Month Performance-86.58%Year-To-Date Performance-91.75%1 Year Performance-93.32% BIVI Stock Chart for Friday, August, 8, 2025 BIVI Chart by TradingView BioVie Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$3.91$2.91-25.58%$3.98$2.86406,276 shs$5.41 million08/06/2025$4.96$3.91-21.17%$5.14$3.57287,541 shs$7.27 million08/05/2025$6.00$4.96-17.33%$6.01$4.86181,984 shs$9.23 million08/04/2025$6.03$6.00-0.50%$6.15$5.7555,340 shs$11.16 million08/01/2025$6.01$6.03+0.33%$6.20$5.7433,174 shs$11.22 million07/31/2025$6.67$6.01-9.90%$6.64$6.0079,244 shs$11.18 million07/30/2025$6.97$6.67-4.30%$7.10$6.6155,333 shs$12.41 million07/29/2025$7.10$6.97-1.83%$7.17$6.7523,173 shs$12.96 million07/28/2025$7.48$7.10-5.08%$7.75$6.8854,119 shs$13.21 million07/25/2025$7.55$7.48-0.93%$7.58$7.3224,201 shs$13.91 million Get the Latest News and Ratings for BIVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$8.24$7.55-8.37%$8.40$7.3844,750 shs$14.04 million07/23/2025$8.19$8.24+0.61%$8.29$8.0022,316 shs$15.33 million07/22/2025$7.31$8.19+12.04%$8.23$7.3571,366 shs$15.23 million07/21/2025$8.99$7.31-18.69%$8.84$7.24107,169 shs$13.60 million07/18/2025$8.05$8.99+11.68%$9.09$8.1553,182 shs$16.72 million07/17/2025$7.31$8.05+10.12%$8.24$7.1694,277 shs$14.97 million07/16/2025$6.99$7.31+4.58%$7.58$7.0143,370 shs$13.60 million07/15/2025$6.62$6.99+5.59%$7.18$6.6245,061 shs$13.00 million07/14/2025$7.14$6.62-7.28%$7.13$6.5452,129 shs$12.31 million07/11/2025$7.57$7.14-5.68%$7.46$7.0767,428 shs$13.28 million07/10/2025$8.05$7.57-5.96%$8.06$7.4559,351 shs$14.06 million07/09/2025$8.47$8.05-4.96%$8.59$8.0494,203 shs$14.97 million07/08/2025$8.10$8.47+4.57%$8.76$7.9145,196 shs$157.29 million07/07/2025$9.62$8.10-15.80%$9.56$6.78247,698 shs$150.42 million Related Companies PDS Biotechnology Stock Chart Century Therapeutics Stock Chart PyroGenesis Canada Stock Chart Actinium Pharmaceuticals Stock Chart Renovaro Stock Chart Adlai Nortye Stock Chart CalciMedica Stock Chart Prelude Therapeutics Stock Chart KALA BIO Stock Chart Cognition Therapeutics Stock Chart Receive BIVI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIVI) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
